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Review
Because of the enormous increase in mobile 
phone use starting in the mid-1990s and 
reaching almost 100% prevalence in many 
countries worldwide by now, concerns have 
been raised that even small risks for developing 
chronic diseases such as cancer from mobile 
phone use may have substantial impact on 
public health. In fact, never before in history 
has any device of comparative preva  lent use 
been associated with such high exposure to 
high-frequency electro  magnetic fields (EMFs). 
(In addition, exposure to extremely low-fre-
quency magnetic fields occurs from battery 
discharge.) Although from the perspective of 
the thermal effects paradigm, the rate of energy 
deposition in tissues of the mobile phone user 
is below levels considered harmful, there has 
been debate since the 1930s that tissue heating 
may not be the only rele  vant effect elicited by 
exposure to high-frequency EMFs; thus, there 
may be a relevant risk that has not been estab-
lished yet because of the scarcity of exposure 
conditions that are comparable across a signifi-
cant proportion of the population. For all the 
diverse high-frequency exposures occurring 
in environ  mental and occupational settings 
ranging from long-waves [a type of amplitude 
modulation (AM) broadcasting with carrier 
frequencies between 153 and 280 kHz] to 
radar waves, only a few long-term observa-
tional studies have been published (for an over-
view, see Ahlbom et al. 2004; Krewski et al. 
2001; Kundi et al. 2004). Similarly scarce are 
long-term animal studies of low-level exposures 
in the pre–mobile phone era. Hence, at the 
time mobile phones were introduced, there 
were insufficient data to decide about health 
risks from low-level exposures, but the pre-
vailing opinion that no rele  vant health effects 
occur at exposures below guideline levels led 
to the expectation that mobile phones are safe. 
However, the exponential growth of mobile 
phone use came as a surprise to the indus-
try as well as to scientists involved in EMF 
risk assessment. Therefore, the existing gaps 
in knowledge should be addressed in both 
experimental as well as epidemiologic inves-
tigations focusing on exposures occurring in 
mobile telecommunications.
Since the mid-1990s, many epidemio-
logic studies of mobile phone use have been 
conducted worldwide, most of them focusing 
on tumors of the head region. Despite the 
growing database, the concerns have not been 
settled and a controversy still exists about pos-
sible adverse health effects. Although some 
may be inclined to attribute the ongoing 
debate to the enormous economic impact of 
modern telecommunication during the past 
decade, this debate also mirrors fundamental 
difficulties and a permissible range of inter-
pretation under circumstances of insufficient 
knowledge. Despite this state of affairs, not all 
arguments that have been put forward in this 
controversy are valid. In the following sections 
I will concentrate on epidemiologic findings 
and their interpretation, although experimen-
tal work deserves similar critical appraisal. 
I will first give a brief overview of the 
results of epidemiologic investigations of 
mobile phone use and tumors of the head 
region. I will then address methodologic 
problems associated with these studies and, 
by application of the pragmatic approach pro-
posed earlier (Kundi 2006), discuss whether 
epidemiologic evidence supports a causal inter-
pretation of an association between mobile 
phone use and brain tumors.
Overview of Epidemiologic 
Studies
Table 1 presents an overview of results of epi-
demiologic studies on the association between 
brain tumors and mobile phone use. Other end 
points include salivary gland tumors (Hardell 
et al. 2004; Lönn et al. 2006; Sadetzki et al. 
2008), uveal melanoma (Stang et al. 2001), 
non-Hodgkin lymphoma (Hardell et al. 2005c; 
Linet et al. 2006), facial nerve tumors (Warren 
et al. 2003), and testicu  lar cancer (Hardell et al. 
2007), but for these diseases the database is 
insufficient to date.
Except for the early cohort study from the 
United States (Dreyer et al. 1999) that was 
stopped by the court after 1 year of follow-up 
and the Danish retrospective cohort study 
(Johansen et al. 2001; Schüz et al. 2006b), all 
investigations have been case–control studies.
The “Overall results” from 25 epidemio-
logic studies listed in Table 1 do not demon-
strate support for an increased risk. Only a few 
risk estimates are significantly elevated, and 
some are even significantly reduced. Risk esti-
mates for longer duration of use are higher, on 
average, than overall estimates, and estimates 
for ipsilateral mobile phone use (i.e., use of 
the mobile phone on the same side where the 
tumor occurred), where available, tend to be 
even higher. Implications of these findings are 
discussed below.
Methodologic Problems
Although a number of established study 
designs in epidemiology have been success-
fully applied in thousands of investigations in 
the past 50 years, perhaps few epidemiologists 
are fully aware of the conditions necessary 
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to detect an existing risk by application of 
these methodologies. Analytical epidemiol-
ogy intends to estimate the risk as a function 
of exposure to an agent by application of one 
of three classical study types: cross-  sectional, 
case–control, and cohort study designs. 
Theoretically, all three types are capable of 
detecting an existing risk under ideal con-
ditions but differ in their sensitivity to the 
effects of extraneous and confounding factors. 
For all study designs, it has to be assumed 
that exposure to the agent can be assessed 
with a certain sensitivity and specificity. In 
the case of mobile phone use, the appropriate 
exposure metric is unknown. Absorption of 
electro  magnetic energy in the body of the user 
depends on technical features of the phone and 
the network, as well as on anatomical features 
and habits of use. At first glance, this situation 
does not seem to be much different from, for 
example, an exposure to an air pollutant that 
also varies in time and space and which internal 
dose will depend on physiologic conditions. 
The problem with mobile telephones is much 
more profound. What aspect of the complex 
exposure condition described by “mobile phone 
use” could be responsible for an effect? It is 
obvious that given a certain indicator of mobile 
phone use, such as years of regular use, cumula-
tive number of calls, cumulative hours of use, 
or cumulative absorption of electromagnetic 
energy in a certain area of the body, there are 
indefinitely many exposure conditions that are 
equivalent under the chosen metric and hence 
induce an equivalence relation in the space of 
exposure patterns that cannot be assessed as to 
its suitability with respect to any outcome meas-
ure without a sound mechanistic theory. 
Another essential problem is related to the 
long induction periods and latencies of tumors 
in the head and neck region. Mobile phone 
use that was insignificant before the mid-1990s 
could not be studied with respect to its influ-
ence during induction period because, in 
almost all users, malignant transformation has 
likely occurred long before exposure to mobile 
phones commenced. Although an influence 
during the initiation phase cannot be ruled 
out, many researchers have expressed the opin-
ion that if there is an effect at all, it is an effect 
on tumor promotion or progression (Johansen 
et al. 2001; Muscat et al. 2000; Stang et al. 
2001). If this is actually the case, several sce-
narios have to be considered. For example, in 
a summary of acoustic neuroma, Mohyuddin 
et al. (2003) found that tumor growth is exhib-
ited in 48–70% of patients, stable tumor vol-
umes in 27–50%, and involution in 2–10%. 
If mobile phone use influences growth rate, 
this influence could result in either restarting 
growth in stable tumors, an increase of growth 
rate in growing tumors, or an inhibition of 
involution. The net result would be an earlier 
onset of symptoms and an earlier diagnosis. 
If there is an effect of the specified type, the 
age incidence function in the exposed popula-
tion would be shifted compared with that of 
the unexposed popu  lation by a fraction of the 
exposure duration, as long as duration of use is 
short compared with the natural history of the 
disease. Given that the age incidence function 
has a positive slope, this shift is equivalent to 
an increased incidence in the exposed popula-
tion for any given age. For simplicity, assume 
that the duration and effect of exposure is 
constant across all age groups. Taking the 
slope for the age incidence function for brain 
tumors as 0.04 [on the log incidence scale 
(Wrensch et al. 2002)], the estimated inci-
dence of brain cancer at any given age would 
be proportional to exp(age × 0.04) in the 
popu  lation as a whole. If the exposed segment 
of the population has an age incidence func-
tion shifted by 2 years, the estimated incidence 
at any given age among the exposed would be 
proportional to exp[(age + 2) × 0.04], resulting 
in an OR of exp(2 × 0.04) = 1.08 for mobile 
phone use. Note that the result is independent 
of the exposure prevalence and depends only 
on the shift of the age incidence function and 
its slope. Given the lower number of mobile 
phone users at an older age, the expected ORs 
from studies with short exposure durations 
(and hence small shifts in the age incidence 
function) are too small to be detected with 
acceptable power. 
The third fundamental problem is related 
to the vast diversity of tumor types to be con-
sidered. The World Health Organization dif-
ferentiates about 50 types of brain tumors 
(Kleihues and Cavenee 2000); there are more 
than a dozen different histologic salivary gland 
tumors, and so forth. Furthermore, in recent 
years molecular histo  pathology revealed many 
differences within certain types of tumors. For 
example, there are at least two clusters of glio-
blastoma multiforme, the most frequent malig-
nant brain tumor in adults: one expresses loss 
of heterozygosity on chromosome 17p with 
mutation of the p53 tumor suppressor gene, 
and the other cluster is charac  terized by an 
amplification of the epidermal growth factor 
receptor oncogene (Schwartzbaum et al. 2006). 
Is it possible that all of these diverse types of 
tumors respond uniformly to mobile phone 
radiation? We cannot hope to extract sensitive 
types by epidemiologic investigations because of 
the small numbers for each distinct type. 
In summary, the three most important 
conditions for epidemiology to arrive at a 
conclusion concerning a potential risk of an 
agent are as follows:
•	It	must	be	possible	to	measure	(at	least	by	
a surrogate marker) the component of the 
agent that is related to the risk.
•	For	agents	that	promote	the	disease	in	ques-
tion, duration of exposure must be a sub-
stantial fraction of the history of the disease.
•	There	must	be	good	a priori reason to select 
specific types of diseases that are sufficiently 
homogenous to support the assumption of 
more or less uniform etiology.
None of these preconditions are met in 
the study of mobile phone use and cancer. As 
a consequence, even substantially increased 
risks might go undetected, and evidence will 
tend to be equivocal.
Do Mobile Phones Cause Brain 
Tumors?
To assess a possible causal relationship between 
an agent and cancer, a pragmatic dialog 
approach has been delineated (Kundi 2006). 
According to this procedure, epidemiologic evi-
dence must be assessed concerning four aspects: 
temporal relation, association, environmental, 
and population equivalence. If there are no 
valid counter arguments against the evidence 
for an association, this suffices for a verdict of 
causation. If epidemiologic evidence is insuffi-
cient, other evidence that increases or decreases 
confidence in a causal relationship could be 
included to come to a conclusion.
Temporal relation. Assessment of tem-
poral relation is not a trivial problem. It is 
impossible to define the point in time when 
a brain tumor started. Before a tumor can be 
diagnosed, which in the case of brain tumors 
occurs either by coincidence, if it is detected 
by imaging techniques applied for other rea-
sons, or because of symptoms produced by 
the growing cell mass, the tumor was present 
for many years or even decades. For menin-
gioma, average induction periods of about 
20–40 years have been calculated in adults, 
based on observations of patients exposed to 
ionizing radiation (Umansky et al. 2008). 
For acoustic neuroma, slow growth, with 
an average volume doubling time of about 
1.7 years, suggests similar induction periods 
(Mohyuddin et al. 2003). For glioma, case 
reports (Kranzinger et al. 2001) and long-term 
follow-up after childhood radiation therapy of 
tinea capitis (Sadetzki et al. 2005) also suggest 
induction periods of decades. Considering a 
temporal relationship between exposure and 
the diverse steps of brain tumor development, 
the following four phases may be differenti-
ated: 1) exposure commenced before the first 
step of malignant transformation; 2) expo-
sure started during the induction phase, which 
could itself last for several years; 3) onset of 
exposure occurred during the non  invasive 
growth phase; and 4) exposure started during 
final (autonomous) growth. In cases 1 and 2, 
exposure might influence malignant transfor-
mation itself and cause de novo occurrence of 
a brain tumor. In case 3, exposure might influ-
ence the fate of the deviating clone and could 
decrease latency or probability of spontaneous 
involution and therefore either increase inci-
dence because of a shift of latency or because Kundi
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Table 1. Overview of results [odds ratios or standardized incidence ratios (95% CIs)] from epidemiologic studies of mobile phone use and brain tumors.
    Cohort size  Average duration    Results for longer  Result for
Study  Type  (no. of cases and controls)  of MP use (years)  Overall results  duration of MP use  ipsilateral MP use
Dreyer et al. 1999  Cohort  133,423 Hand-held MP  ~ 2  2 Brain tumor deaths  —  —
    152,138 Portable bag    4 Brain tumor deaths
Hardell et al. 1999  Case–control  209 Brain tumor cases  ~ 6   0.98 (0.69–1.41)  > 10 years, 1.20 (0.56–2.59)  2.42 (0.97–6.05)
Hardell et al. 2000
Hardell et al. 2001  425 Controls            2.62 (1.02–6.71) (multiv)
Muscat et al. 2000  Case–control  469 Malignant brain tumor  ~ 3   0.85 (0.6–1.2)  ≥ 4 years, 0.7 (0.3–1.4)   2.01 (0.92–5.89)
      cases
    422 Controls
Inskip et al. 2001  Case–control  489 Glioma  ~ 3   1.0 (0.7–1.4)  ≥ 5 years, 0.6 (0.3–1.4)   0.86 (0.65–1.35) (overall)
    197 Meningioma    0.8 (0.5–1.2)   0.9 (0.3–2.7)
    96 Acoustic neuroma    0.8 (0.5–1.4)  1.9 (0.6–5.9)
    799 Controls
Johansen et al. 2001   Retrospective cohort  420,095 Subscribers  2001, ~ 3  1.0 (0.8–1.1)  ≥ 3 years, 1.2 (0.6–2.3)      —
Schüz et al. 2006b      2006, ~ 8   1.0 (0.9–1.1)  ≥ 10 years, 0.66 (0.44–0.95)
Auvinen et al. 2002  Case–control  398 Brain tumor cases  Analog, ~ 2.5  1.6 (1.1–2.3)  > 2 years, 1.6 (0.9–2.8)       —
    1,986 Controls  Digital, ~ 1   0.9 (0.5–1.5)  0.6 (0.1–4.5)
Muscat et al. 2002  Case–control  90 Acoustic neuroma  ~ 3  0.68 (0.34–1.38)  ≥ 3 years, 1.7 (0.5–5.1)   0.55 (0.50–1.05)
    86 Controls
Hardell et al. 2002a  Case–control  1,303 Brain tumor cases  Analog, ~ 7   1.3 (1.02–1.6)   > 10 years, 1.8 (1.1–2.9)   1.8 (1.3–2.5)
      Digital, ~ 4,   1.0 (0.8–1.2)  —  1.3 (0.99–1.8)
      Cordless, ~ 6   1.0 (0.8–1.2)  2.0 (0.5–8.0)  1.3 (1.01–1.8)
    611 Meningioma  Analog, ~ 7   1.1 (0.7–1.5)   > 10 years, 1.0 (0.1–16.0)      —
      Digital, ~ 4   0.8 (0.6–1.03)  —
      Cordless, ~ 6   0.9 (0.6–1.1)  —
    159 Acoustic neuroma  Analog, ~ 7   3.5 (1.8–6.8)  > 10 years, 3.5 (0.7–16.8)      —
      Digital, ~ 4   1.2 (0.7–2.2)  —
    1,303 Controls  Cordless, ~ 6   1.0 (0.6–1.7)  2.0 (0.2–22.0)
Hardell et al. 2002ba  Case–control  588 Malignant brain tumor  Analog, ~ 7   1.13 (0.82–1.57)  > 6 years, 1.17 (0.75–1.81)  1.80 (0.96–3.38) > 6 years
      cases  Digital, ~ 4   1.13 (0.86–1.48)  1.71 (0.67–4.34)  2.29 (0.59–8.93)
    581 Controls  Cordless, ~ 5   1.13 (0.85–1.50)  1.56 (0.92–2.63)  1.16 (0.55–2.46)
Christensen et al. 2004  Case–control  106 Acoustic neuroma  ~ 4   0.90 (0.51–1.57)  ≥ 10 years, 0.22 (0.04–1.11)   0.68 (0.58–0.90)
    212 Controls
Lönn et al. 2004a  Case–control  148 Acoustic neuroma  ~ 5   1.0 (0.6–1.5)   ≥ 10 years, 1.9 (0.9–4.1)   3.9 (1.6–9.5) ≥ 10 years
    604 Controls
Christensen et al. 2005  Case–control  175 Meningioma  ~ 5   0.83 (0.54–1.28)   ≥ 10 years, 1.02 (0.32–3.24)
    81 Glioma I-II    1.08 (0.58–2.00)  1.64 (0.44–6.12)
    171 Glioma III-IV    0.58 (0.37–0.90)  0.48 (0.19–1.26)
    822 Controls
Hardell et al. 2006a  Case–control  317 Malignant brain tumor  Analog, ~ 10   2.6 (1.5–4.3)   > 10 years, 3.5 (2.0–6.4)  3.1 (1.6–6.2)
      cases  Digital, ~ 6   1.9 (1.3–2.7)  3.6 (1.7–7.5)  2.6 (1.6–4.1)
    692 Controls  Cordless, ~ 6   2.1 (1.4–3.0)  2.9 (1.6–5.2)   2.9 (1.8–4.7)
Hardell et al. 2005a  Case–control  305 Meningioma   Analog, ~ 9   1.7 (0.97–3.0)   > 10 years, 2.1 (1.1–4.3)  1.6 (0.7–3.9)
      Digital, ~ 5   1.3 (0.9–1.9)  1.5 (0.6–3.9)  1.5 (0.9–2.5)
      Cordless, ~ 5   1.3 (0.9–1.9)  1.9 (0.97–3.6)  1.6 (0.97–2.6)
    84 Acoustic neuroma  Analog, ~ 9   4.2 (1.8–10)   > 10 years, 2.6 (0.9–8)   5.1 (1.9–14)
       Digital, ~ 5   2.0 (1.05–2.8)  0.8 (0.1–6.7)  2.9 (1.4–6.1)
    692 Controls  Cordless, ~ 5   1.5 (0.8–2.9)  0.3 (0.03–2.2)  2.4 (1.1–5.1)
Lönn et al. 2005  Case–control  371 Glioma  Analog, ~ 9  0.8 (0.5–1.2)   ≥ 10 years, 0.8 (0.5–1.5)   1.6 (0.8–3.4) ≥ 10 years
      Digital, ~ 3   0.8 (0.6–1.0)  ≥ 5 years, 0.8 (0.6–1.2)
    273 Meningioma  Analog, ~ 9   0.7 (0.4–1.3)   ≥ 10 years, 0.9 (0.5–2.0)   1.3 (0.5–3.9) ≥ 10 years
    674 Controls  Digital, ~ 3   0.6 (0.5–0.9)  ≥ 5 years, 0.8 (0.5–1.2)
Schoemaker et al. 2005b  Case–control  678 Acoustic neuroma  Analog, ~ 8   0.9 (0.7–1.2)   ≥ 10 years, 1.1 (0.7–1.7)   1.8 (1.1–3.1) ≥ 10 years
    3,553 Controls  Digital, ~ 4   0.9 (0.7–1.1)  0.7 (0.2–3.5)
Hepworth et al. 2006  Case–control  966 Glioma  ~ 5   0.94 (0.78–1.13)   ≥ 10 years, 1.14 (0.74–1.73)  1.24 (1.02–1.52)
    1,716 Controls
Schüz et al. 2006a  Case–control  366 Glioma  ~ 4   0.98 (0.74–1.29)  ≥ 10 years, 2.20 (0.94–5.11)
    381 Meningioma    0.84 (0.62–1.13)  1.09 (0.35–3.37)
    1,494 Controls
Klaeboe et al. 2007  Case–control  289 Glioma  ~ 4   0.6 (0.4–0.9)   ≥ 6 years, 0.8 (0.5–1.2)   1.2 (0.7–1.2) ≥ 6 years
    207 Meningioma    0.8 (0.5–1.1)  1.0 (0.6–1.8)  1.4 (0.7–2.9)
    45 Acoustic neuroma    0.5 (0.2–1.0)  0.5 (0.2–1.5)  0.7 (0.2–2.5)
    358 Controls
Takebayashi et al. 2006  Case–control  101 Acoustic neuroma  ~ 4   0.73 (0.43–1.23)   ≥ 8 years, 0.79 (0.24–2.65)   0.90 (0.50–1.62)
    339 Controls
Lahkola et al. 2007c  Case–control  1,521 Glioma  ~ 6   0.78 (0.68–0.91)  ≥ 10 years, 0.95 (0.74–1.23)   1.39 (1.01–1.92) ≥ 10 years
    3,301 Controls
Schlehofer et al. 2007  Case–control  97 Acoustic neuroma  ~ 4   0.67 (0.38–1.19)
    194 Controls
Hours et al. 2007  Case–control  96 Glioma    1.15 (0.65–2.05)  > 4 years, 1.96 (0.74–5.20)
    96 Controls
    109 Acoustic neuroma    0.92 (0.53–1.59)  > 4 years, 0.66 (0.28–1.57)
    214 Controls
Takebayashi et al. 2008  Case–control  88 Glioma  ~ 4   1.22 (0.63–2.37)  > 6.5 years, 0.60 (0.20–1.78)  1.24 (0.67–2.29)
    132 Meningioma    0.70 (0.42–1.16)  > 5.2 years, 1.05 (0.52–2.11)  1.14 (0.65–2.01)
    392 Controls
Lahkola et al. 2008d  Case–control  1,209 Meningioma  5.5   0.76 (0.65–0.89)  ≥ 10 years, 0.85 (0.57–1.26)  0.99 (0.57–1.73) ≥ 10 years 
    3,299 Controls
Abbreviations: CI, confidence interval; MP, mobile phone; multiv, multivariate.
aData are a subset from Hardell et al. (2002a). bIncludes data from Christensen et al. (2004) and Lönn et al. (2004a). cIncludes data from Lönn et al. (2005), Christensen et al. (2005), Hepworth et al. (2006), 
and Klaeboe et al. (2007). dIncludes data from Lönn et al. (2005), Christensen et al. (2005), and Klaeboe et al. (2007).Mobile phones and cancer
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a tumor that would otherwise remain obscure 
during lifetime manifests itself clinically. In 
case 4, no contribution of exposure is pos-
sible. Unfortunately, little is known about the 
duration of these phases. Furthermore, there 
are likely gross differences between tumor 
types concerning absolute and relative length 
of these steps during natural history of the 
disease. Although slowly growing tumors such 
as most meningioma and schwannoma may 
have unchanged growth rates during pro-
longed periods of time, other brain tumors 
such as glioblastoma show an explosive final 
growth after possibly long periods of more 
stable behavior. For radiation-induced tumors, 
Cahan et al. (1948) proposed to allow at least 
5 years for induction periods. As delineated 
above, for an effect during latent growth to 
be detected in epidemiologic studies, exposure 
must have been during a substantial propor-
tion of growth phase. Therefore, for an influ-
ence both during the induction phase and on 
tumor growth rate, at least 5 years must be 
allowed for latency or duration of exposure, 
respectively, to fulfill the criterion of temporal 
relation. Because for virtually all carcinogens, 
repetitive or prolonged exposures are necessary 
to bring about an increased cancer incidence, 
it is necessary to consider not only time since 
first exposure but also duration of exposure. 
Number of calls and average duration of calls 
seem to be too difficult to remember for peri-
ods far in the past, but information about peri-
ods of regular use is more easily recalled and 
therefore could be the best choice for exposure 
determination. (In principle, it may even be 
validated by network provider data). Years of 
regular mobile or cordless phone use up to 
5 years before diagnosis would possibly be the 
appropriate exposure meter for most slowly 
growing tumors. Because such evaluations 
have not been performed, I instead assessed 
exposure duration or latency of ≥ 10 years, as 
available, for Table 1. In these subjects, at least 
half of the exposure duration falls within an 
etiologically relevant period. 
Association. I computed a meta-analyti-
cal estimate of the risk for the different brain 
tumor types based on all independent studies 
reporting ORs for ≥ 10 years of mobile phone 
use. Heterogeneity was assessed by chi-square 
tests. A p-value < 0.05 was considered signifi-
cant. If studies included the same population, 
only those without overlap were considered in 
the meta-analyses. Pooled effects and SEs were 
derived from the fixed-effect model because no 
significant heterogeneity was detected. Because 
basically all investigations used the same study 
design and the same end point definition, 
despite some deviations in exposure classifica-
tion and proneness to misclassification and 
selection bias, no attempt was made in the 
meta-analysis to account for these differences. 
It should, however, be noted that correction for 
selection and misclassification bias would lead 
to higher meta-analytical odds ratios. There is 
no publication bias in this case because all stud-
ies that are planned, on  going, or completed are 
known to the scientific community. 
For glioma, I included three studies (Hardell 
et al. 2006c; Lahkola et al. 2007; Schüz et al. 
2006a) reporting data on 233 exposed cases 
and 330 exposed controls among 2,792 glioma 
patients and 6,195 control subjects. I found 
no heterogeneity across studies, and the com-
bined OR was 1.5 [95% confidence interval 
(CI), 1.2–1.8]. For acoustic neuroma, two 
independent pooled analyses (Hardell et al. 
2006b; Schoemaker et al. 2005) gave an over-
all OR of 1.3 (95% CI, 0.95–1.9), based on 
67 exposed cases and 311 exposed controls 
among 912 and 5,715 cases of acoustic neu-
roma and controls, respectively. Risk for men-
ingioma from mobile phone use of ≥ 10 years 
was reported in two individual studies (Hardell 
et al. 2006b; Schüz et al. 2006a) and one 
pooled study (Lahkola et al. 2008), with an 
overall OR of 1.1 (95% CI, 0.8–1.4) evalu-
ated from 116 exposed cases and 320 controls 
among a total of 2,506 meningioma patients 
and 6,223 control subjects. Hence, there is an 
increased risk for all of these end points from 
mobile phone use that is statistically significant 
for glioma. In these analyses mobile phone use 
was assumed to induce the neoplasia. If mobile 
phone use has an additional or exclusive effect 
on tumor growth, this analysis is not entirely 
appropriate because an effect on the grow-
ing tumor can only be exerted by exposure 
on the same side of the head where the tumor 
is located. Combined estimates for ipsilateral 
mobile phone use of ≥ 10 years give the ORs: 
1.9 (95% CI, 1.4–2.4) for glioma; 1.6 (95% 
CI, 1.1–2.5) for acoustic neuroma; and 1.3 
(95% CI, 0.9–1.9) for meningioma. Hence, 
there are clear indications of increased risks for 
all three end points. 
According to the dialogue approach, 
association must be assessed whether or not 
there are valid counter  arguments, and espe-
cially those based on considerations about the 
impact of possible biases.
Potential biases. As apparent from 
Table 1, ever (regular) use of a mobile phone 
rarely revealed increased risks for any type of 
brain tumor. Except for the Finnish study 
of Auvinen et al. (2002), only the Swedish 
group of Hardell and colleagues (e.g., Hardell 
et al. 2002a) reported significantly elevated 
estimates of relative risks. 
Most studies summarized in Table 1 were 
conducted based on the Interphone protocol 
(Cardis et al. 2007) that defined regular use as 
at least one outgoing or incoming call per week 
for at least 6 months, with ever-regular use start-
ing 1 year before the reference date. Although 
the reference date was defined as date of diag-
nosis in cases and the same date of the matched 
control, in studies not individually matched 
(e.g., Hepworth et al. 2006), there are problems 
in defining the reference date because of the 
interview lag time. Because of the rapid increase 
in mobile phone use during and before the 
study period, the methods applied to compute 
the reference date for controls could be a source 
of bias. Information provided in the study 
reports is insufficient to decide whether adjust-
ments were biased. In some articles (Hepworth 
et al. 2006; Schoemaker et al. 2005), controls 
were allocated into categories of interview lag 
time at random without consideration of age 
and sex of the cases within these categories, 
whereas in others (Lönn et al. 2004a), aver-
age lag between diagnosis and identification 
in a matched set was subtracted from date of 
control identification. The first method intro-
duces bias if distribution of age and sex within 
categories of lag times differs, and the second 
method introduces bias if the date of identifi-
cation differs between cases and controls. To 
my knowledge, these possible biases have not 
been considered previously. In the Interphone 
study (Cardis et al. 2007), data were collected 
from the end of 2000 through the beginning of 
2004, with some differences between countries. 
During this period, mobile phone penetra-
tion rate increased from about 60% to about 
90% in the European Union, according to 
the International Telecommunication Union. 
Insufficient adjustment for differences in the 
interview date would result in under  estimation 
of risk. 
In their studies, Hardell and colleagues 
disregarded mobile and cordless phone use 
within the last year before the reference date. 
Any use of a mobile or cordless phone was 
counted except when hands-free devices or 
external car antennas were used. The reference 
date for controls was set to the date of diag-
nosis of the matched case. In some reports of 
pooled data sets (e.g., Hardell et al. 2006c), 
individual matching was disregarded and con-
trols from different studies were included. 
Insufficient adjustment of the reference date 
could have also led to bias in this case. 
Hardell and colleagues defined the unex-
posed subjects as those who have not used a 
mobile or cordless phone for ≥ 1 year before 
diagnosis (or reference date in controls). The 
Interphone group disregarded cordless phones 
in analyses of mobile phone use (and vice 
versa). Cardis et al. (2007) and Takebayashi 
et al. (2006) have argued that cordless phone 
use is associated with much lower exposure to 
microwaves and therefore cannot be counted 
in exposure assessments. This view is not cor-
rect. Average power levels are not much dif-
ferent between cordless phones (average levels 
of 10 mW) and mobile phones (median aver-
age output power 6–16 mW in urban areas) 
(Lönn et al. 2004b). Considering the typi-
cally longer duration of daily use of cordless Kundi
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phones compared with mobile phones, it 
is not a rational procedure to exclude them 
from total exposure (for information on ado-
lescent users, see Söderqvist et al. 2008). The 
fraction of cordless phone users among cases 
and controls not using mobile phones ranged 
from about 22% in the study of Hardell 
et al. (2006b) to almost 40% in the German 
Interphone study (Schüz et al. 2006a). If we 
arbitrarily assign sensitivity of exposure deter-
mination from omission of cordless phone 
use a value of 74% in cases and 78% in con-
trols, assuming 100% specificity (in cases and 
controls) and an actual exposure prevalence of 
54% [according to the data of Hardell et al. 
(2006b)], a true OR of 1.5 would be reduced 
to 1.2. Still greater reductions of the OR 
result if the differences in cordless phone use 
were actually greater.
In the Interphone studies, data acquisi-
tion concerning exposure was predominantly 
done by computer-assisted personal interview 
(CAPI). In about 95% of glioma cases and 
controls, exposure assessment was based on 
CAPI (Cardis et al. 2007). Reports from five 
Nordic countries (Lahkola et al. 2007) reveal 
that > 40% of cases were interviewed in the 
hospital. However, this fraction ranges from 
almost 100% in Finland to 3% in the United 
Kingdom. Data acquisition was completely dif-
ferent in the studies of Hardell and colleagues 
(Hardell et al. 2002a). They sent a question-
naire to home addresses of cases and controls, 
and upon return, they evaluated the question-
naires for errors, omissions, and discrepancies. 
If necessary, additional information was sought 
by telephone interviews blinded to case status. 
Method of data acquisition could be 
important in several respects: a) interviews 
not blinded to case status may introduce a 
bias from the expectations of the interviewer; 
b) the interaction between interviewee and 
interviewer as such can lead to bias (Rosenthal 
effects); c) answering a questionnaire at home 
is less demanding (especially considering 
the conditions after surgery) than personal 
interviews; d) at home it is possible to check 
telephone bills or to inspect contracts with 
network providers to verify data. For these 
reasons, the questionnaire method seems to be 
superior to the interview technique. However, 
there are also advantages of the CAPI method: 
data can be immediately checked for errors 
and discrepancies, and the interviewer can 
explain points that are not clear and may help 
in recalling inquired items. Validation stud-
ies (Berg et al. 2005; Vrijheid et al. 2006a, 
2006b) within the Interphone study showed 
only a moderate correlation between self-
reported intensity of mobile phone use and 
traffic data from network operators, but con-
firmed usage data as valid proxy for micro-
wave exposure. For the (not very important) 
recent mobile phone use, self reports seem to 
be fairly accurate, but for earlier use, no data 
on reliability are available. Considering results 
from Christensen et al. (2005), memory per-
formance is decreased especially in patients 
with high-grade glioma. Exposure assessment 
in these patients could be particularly biased 
if conducted by interviews compared with the 
questionnaire method. Bias often represents 
underreporting of mobile phone use, because 
it is more likely that a patient forgot using a 
mobile phone once years ago compared with 
falsely stating mobile phone use.
In the Interphone studies, overall partici-
pation was 65% for glioma cases, 78% for 
meningioma, and 82% for acoustic neuroma 
(Cardis et al. 2007). For controls, participa-
tion was 53% but there was large variation 
across centers, ranging from 35% to 74%. 
Hardell et al. (2006d), using postal question-
naires, reported participation rates of 88–91% 
in cases and 84–92% in controls. The par-
ticipation rate in cases was computed based 
on eligible cases that received a questionnaire, 
defined as those with ascertained primary 
brain tumors alive at the time of identifica-
tion and whose participation was not denied 
by their physician. If the definition of eligible 
cases for the Interphone studies were applied, 
the participation rate would amount to about 
65–85% in the different studies of Hardell 
and colleagues. In the Interphone studies, on 
average, 13% (range, 2–44%) of case inter-
views were performed as proxy interviews. 
As shown by Vrijheid et al. (2006a) in an 
Interphone validation study, response bias due 
to differential selection of groups of the popu-
lation with higher prevalence of mobile phone 
use possibly has the highest impact, even 
outweighing recall bias. Lönn et al. (2005) 
showed that non  participating cases had almost 
the same proportion of mobile phone users 
(50% compared with 52% in participants), 
but non  participating controls differed mark-
edly from participants (34% compared with 
59%). Effect of this selection bias might be 
even greater if long-term use is considered. 
Consequence of selection bias can easily be 
determined because the biased OR is equal 
to the product of the true OR and the selec-
tion OR (cf. Rothman et al. 2008). Given the 
non  response analysis of Lönn et al. (2005), 
the selection OR is computed as 0.64 if over-
all participation rates of the Interphone stud-
ies are considered (72% and 53% in cases 
and controls, respectively). All 46 ORs in the 
report of Lönn et al. (2005), except one in the 
overall analysis of glioma and meningioma, 
were < 1. Assuming the selection OR is 0.75 
as computed based on the participation rates 
for the Lönn study specifically (79% in cases 
and 70.5% in controls), almost all these ORs 
would increase above 1 and none would be 
significantly < 1 (as was the case for 7 of the 
46 ORs). For example, the OR for > 10 years 
of mobile phone use for glioma, reported as 
0.9, would increase to 1.2. 
As has been pointed out previously (Kundi 
2004; Kundi et al. 2004; Schoemaker et al. 
2005), early symptoms of a developing brain 
tumor may have influenced behavior regarding 
mobile phone use. In particular, growing acous-
tic neuroma are frequently associated with hear-
ing problems and tinnitus. Such symptoms may 
lead to a restriction of use, change of the side of 
the head the phone is held during calls, and 
even to discontinuing mobile phone use. Lönn 
et al. (2004a), in their study of acoustic neu-
roma, assessed impact of hearing loss and tin-
nitus 5 years before reference date and reported 
no differences in risk estimates for patients with 
and without hearing loss. Whether this is an 
indication that such symptoms have no impact 
on mobile phone use and therefore do not bias 
risk estimates is difficult to assess because no 
data were reported. As noted by Schoemaker 
et al. (2005), 59% of regular phone users 
among controls reported predominantly right-
sided use, 33% left-sided use, and 8% use on 
both sides. The authors argued that if mobile 
phones cause acoustic neuromas, one might 
expect a higher proportion of tumors on the 
right than on the left side of the head among 
regular phone users. However, this expectation 
is completely unfounded. In contrast, tumor 
growth may cause behavioral changes, as indi-
cated by the distribution of mobile phone use 
in cases, with only 49% right-sided users, 40% 
left-sided users, and 11% that used the phone 
on both sides. 
Although response bias, misclassifi  cation 
bias, and insufficient correction of inter-
view lag time between cases and controls will 
reduce risk estimates toward or even below 
unity, some biases could lead to a spuriously 
increased risk. One particular point has been 
raised frequently: Increased risk estimates of 
ipsilateral mobile phone use (Table 1) could be 
due to recall bias. If mobile phone use affects 
tumor development and growth, it is impor-
tant to consider the side of the head to which 
the phone is held during calls. Cardis et al. 
(2008) reported that 97–99% of the total elec-
tromagnetic energy deposited in the brain is 
absorbed at the side of the head the phone is 
held during calls. Because of this asymmetry, 
an effect at the site of the growing tumor is 
expected only or primarily for ipsilateral use. 
There is no objective method to retrospectively 
assess side of the head the phone has been 
used. Asking a person about this aspect of use 
could result in bias. A person may be inclined 
to suspect mobile phone use as a causal fac-
tor and may therefore tend to report using it 
at the same side as the tumor has occurred. 
On the other hand, the reverse also may be 
claimed—that a person wants to dismiss the 
possibility that using the phone has anything 
to do with the disease and is therefore falsely Mobile phones and cancer
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reporting the opposite side of use. Even if 
a patient does not intentionally distort the 
answer, recent surgery may cause memory 
deficiencies leading to recall bias. Hepworth 
et al. (2006) argued that the reduced risk on 
the contra  lateral side indicates such recall bias. 
However, this risk reduction was due to an 
artifact of the method applied. Estimate of 
relative risk for contra  lateral mobile phone 
use was based on non  regular and ipsilateral 
phone users as reference. It follows that when-
ever the relative risk of ipsilateral phone use is 
> 1, the relative risk of contra  lateral use must 
be < 1 [the expected value of the OR in this 
case is (πo+πi)/(πo+ψπi), where πo is the pro-
portion in the population of nonusers, πI is 
the proportion in the population of ipsilat-
eral users, and ψ is the OR for ipsilateral use]. 
All meta-analytical ORs for ipsilateral mobile 
phone use are > 1, and those for glioma and 
acoustic neuroma are statistically significant. If 
there was no misclassification bias in controls 
and perfect sensitivity, then a small recall bias 
in the direction of a preference for reporting 
mobile phone use at the side of the tumor of 
about 3% would reduce these enhanced ORs 
for long-term (≥ 10 years) use to 1. However, 
considering overall results for ipsilateral use, 
recall bias must reduce specificity in cases by 
30–40% to remove the observed enhanced 
risk. The specificity that reduces an observed 
increased OR to 1 is given by [1+(ψ*–1)π]–1, 
where ψ* is the observed OR and π is the 
exposure prevalence in the population, given 
that sensitivity in both cases and controls 
and specificity in controls are 1 (Rothman 
et al. 2008). For example, taking the study 
of Hardell et al. (2005a) with an overall OR 
for ipsilateral mobile and cordless phone use 
of approximately 3.0 for acoustic neuroma 
and a prevalence of about 23% of ipsilateral 
mobile or cordless phone use, the specificity 
must be as low as 68% to remove the observed 
effect. That is, 32% of those not exposed at 
all or not on the side of the tumor must have 
falsely stated they have been exposed. In other 
words, more than half of mobile phone users 
among cases and none among controls must 
have given the wrong side of the head for 
their predominant use to remove the observed 
increased risk. It should also be noted that 
the case-only approach of Takebayashi et al. 
(2008) cannot solve the problem of recall bias.
As can be seen in Table 1, several 
Interphone groups (Christensen et al. 2005; 
Klaeboe et al. 2007; Lahkola et al. 2007, 2008; 
Lönn et al. 2005) reported ORs that were sig-
nificantly < 1, implying a protective effect of 
mobile phone use for brain tumors. Although 
there is a remote possibility that mobile phone 
use may enhance apoptosis or activate DNA 
repair, such processes will hardly affect tumor 
develop  ment at an advanced stage; thus, this 
is not a valid explanation for these reduced 
risk estimates but rather it suggests systematic 
bias. Selection bias, as delineated above, could 
explain some of these results. However, there 
are likely additional biases that contributed to 
the overall effect. Let us consider this aspect 
from the perspective of the ceteris paribus con-
dition (i.e., that cases and controls have essen-
tially the same features in all relevant aspects 
except exposure) and in particular from the 
condition of population equivalence (i.e., 
the condition that both cases and controls 
stem from populations that are equivalent 
for all attributes that are relevant for the dis-
ease under study). Mobile phone use is not 
randomly distributed within the population, 
but usage patterns will be associated with cer-
tain attributes such as occupation, sex, socio-
economic status (SES), and age. Some of these 
attributes can be accounted for by matching or 
during analy  sis, but there could be an associa-
tion with the disease that cannot be removed 
by these procedures. Exploration of prior 
symptoms in brain tumor cases often reveals 
indications of the disease process many years 
in the past (e.g., epileptic seizures, personality 
changes, a variety of cognitive and perception 
problems). Some of these symptoms could 
reduce the probability that a person chooses 
to use a mobile phone—or a telephone in gen-
eral. Such habit changes would have the great-
est impact on measures of cumulative duration 
and intensity of use. If aspects of the disease 
influence mobile phone use, the ceteris paribus 
condition is violated from the very beginning. 
It is evident that this also implies a violation of 
the condition of temporal relation, because a 
reversal of cause and effect may occur. These 
difficulties are related to the generally short 
duration of mobile phone use. A solution 
could be inclusion of case history information 
and formation of distinct subgroups differing 
in duration of symptoms related to the devel-
oping disease. Obviously, influence of symp-
toms on mobile phone use will predominantly 
reduce risk estimates, because the odds for 
mobile phone use in cases will be lowered. 
Because of the mentioned biases that could 
operate in case–control studies, one may be 
inclined to put some weight on the only cohort 
study (Johansen et al. 2001; Schüz et al. 2006b) 
presently available. However, this investigation 
is severely flawed and cannot contribute to risk 
assessment and was therefore not included in 
the meta-analysis (see also Hardell et al. 2008).
Confounding. Environmental equivalence 
seems to be sufficient in all investigations and 
confounding seems an unlikely cause of bias 
because there are only a few known risk fac-
tors for brain tumors that would induce bias if 
disregarded in the analyses. Therapeutic and, 
to a lesser degree, diagnostic X rays to the head 
region increase the risk for several types of 
brain tumors. In some studies this was consid-
ered a possible confounder but without effect 
on the risk estimates (e.g., Hardell et al. 2001), 
indicating that there is no correlation between 
such irradiation and mobile phone use. Other 
possible confounders include neuro  fibro-
matosis and tuberous sclerosis, family history 
of brain tumors, and medical treatment with 
growth factors, all of which are very rare con-
ditions without reason to assume a relationship 
with mobile phone use. Age and sex are the 
most important confounders that have been 
considered in all studies either by matching or 
during analysis. SES has also been indicated 
as a possible confounder and was included 
in most analyses. However, including SES in 
the analysis will not remove selection bias that 
seems to be related to SES in some Interphone 
investigations (e.g., Hepworth et al. 2006).
Assessment. Overall, arguments in favor 
of or against an association between mobile 
phone use and brain tumors are not equally 
strong. There is evidence for selection bias, 
exposure misclassification from excluding cord-
less phone use, reversal of cause and effect from 
neglecting early symptoms of the disease, and 
short exposure duration. All these factors lead 
to reduction of the observed risk estimates. 
The only strong argument against an asso-
ciation is the possible impact of recall bias. 
There may be under  reporting especially of early 
mobile phone use because of memory deficits 
after surgery, but most concerns have been 
raised for a potential distortion in reporting 
side of the head the phone is held during calls. 
Handedness correlates not very highly with side 
of the head the phone is used [concordances 
of only about 60% have been determined 
(Hepworth et al. 2006)], and there are no 
other methods at hand to validate these data. 
There are, however, some arguments that speak 
against a decisive influence of recall bias: Most 
participants of the Interphone and Hardell 
studies were enrolled during 1997–2003 at a 
time when mobile phone use was not widely 
discussed as a potential risk factor for brain 
tumors. As reported by Hardell et al. (2002a), 
among 232 brain tumor cases who expressed 
their views about potential causes of their dis-
ease, only two named mobile phones. Lönn 
(2004) asked 70 brain tumor cases and con-
trols whether they considered mobile phones 
as a risk factor for brain tumors and found 
no difference between both groups. Even if 
patients consider mobile phones a factor con-
tributing to their disease, what would they gain 
if they gave the wrong side of use? Most people 
choose to use mobile phones, but do they want 
to blame themselves for their disease? In several 
studies, mobile phone use was only one of the 
different risk factors investigated (e.g., Lönn 
et al. 2006). Bias from patients’ attribution 
would likely extend also to these other factors, 
and spuriously increased risks should have been 
observed in some of them. Although report-
ing bias of this type may explain an increased Kundi
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risk for long-term ipsilateral use, it is hardly 
an explanation for the increased overall risk of 
ipsilateral use revealed in several investigations 
(Hardell et al. 2002a, 2005a, 2006a; Hepworth 
et al. 2006). 
When considering the discussion above, 
the conditions for a causal interpretation of the 
observed association between mobile phone use 
and brain tumors are not fully met. However, 
discussion of the potential violation of the con-
ditions of temporal relation as well as popula-
tion and environmental equivalence revealed 
that it must in all likelihood have reduced the 
observed association. Because of the important 
result on ipsilateral mobile phone use, a spuri-
ously increased risk due to recall bias cannot 
be completely dismissed. In such a situation, 
evidence from other sources may increase or 
decrease confidence in a causal relation between 
mobile phone use and cancer. 
Additional evidence. Since the 1930s there 
has been a scientific controversy about effects 
of high-frequency EMF other than thermal. 
Absorption of electro  magnetic energy is now 
well understood and poses no principal dif-
ficulty of integration into Maxwell’s theory 
of electromagnetism. The rate of absorption 
of electromagnetic energy in a homogenous 
volume of biological tissue is proportional to 
the temperature increase within this volume. 
Therefore, at high levels of EMF exposure, sig-
nificant heating occurs that can be dangerous 
to health. Exposure standards have been issued 
that limit exposure to thermally safe levels. 
However, telecommunication and broadcast-
ing applications of high-frequency EMF are 
not only radiating energy but also informa-
tion. This is done by modulation of the high-
frequency carrier. The modulation frequencies 
could be of biological significance and evoke 
nonthermal effects. In addition, the high-fre-
quency signal itself could cause effects at low 
levels in combination with the simultaneous 
presence of the earth magnetic field (Chiabrera 
et al. 2000). In principle, interactions between 
EMF and matter are subject to two descrip-
tions, classical or quantum electro  dynamics. In 
a living cell, many important processes occur 
by electron transfer across membrane struc-
tures in a well-organized manner, ions cross 
selective channels, proteins get activated and 
deactivated by cascades of precisely regulated 
enzymes—all processes that occur on a quan-
tum scale. Recently, by application of “omics” 
research (for an overview, see Vanderstraeten 
and Verschaeve 2008), it has been shown that 
cells may respond with activation of proteins 
and genes at nonthermal levels of exposure, a 
process that was also observed in vivo (Karinen 
et al. 2008). However, because of the lack of a 
mechanistic model, these results are uncertain 
as to their interpretation with respect to rel-
evant long-term health effects. It has long been 
speculated (Lai and Singh 1997; Phelan et al. 
1992) that free radical formation is involved in 
EMF-induced health effects. Although there is 
some evidence of formation of free radicals 
at nonthermal levels of EMF (Simkó et al. 
2006), there are many difficulties with this 
approach. It would be much too simplistic to 
assume that free radicals are directly produced 
by the interaction with the EMF. Rather, these 
radicals are produced by the cell itself as an 
intermediate step of the response to sensing 
the field (Friedman et al. 2007). 
Concerning prior epidemiologic evidence 
of a relationship between high-frequency EMF 
other than those used in mobile telecommuni-
cation and brain tumors, despite some reports 
of increased risk (Berg et al. 2006; Grayson 
1996; Szmigielski 1996; Thomas et al. 1987), 
the evidence is inconclusive to date.
Results of epidemiologic studies of mobile 
phone use summarized above indicate an asso-
ciation that is of moderate strength and in the 
range delineated for passive smoking and lung 
cancer. There is no meaningful indicator of 
exposure dose available, but longer latencies 
are associated with higher risk estimates, and 
there are indications that risk is higher in rural 
areas where phones typically radiate at higher 
intensities (Hardell et al. 2005b). These aspects 
do increase confidence in a causal relationship.
In the case that epidemiology faces prob-
lems due to short exposure durations, lifetime 
animal bioassays gain importance in estab-
lishing a carcinogenic risk. Unfortunately, 
standard procedures cannot be applied for 
exposure to microwaves from mobile phones. 
In hundreds of animal carcinogenicity assays, 
it has been shown that even for DNA reac-
tive agents, exposure during most of the life 
span of the animals at the maximum tolerated 
dose is necessary to significantly increase inci-
dence. Such high exposures are impossible for 
high-frequency EMF because of interference 
with heating. Hence, it is necessary to apply 
levels that are much too low for an increased 
incidence to be expected. Some solutions to 
this problem have been proposed: a) coexpo-
sure or prior exposure to a known carcino-
gen; b) implantation of tumor cells; and c) use 
of animal strains with a habitually increased 
tumor incidence. Because of the unknown 
mechanism of action, none of these attempts 
can be evaluated according to their suitability. 
More than 30 long-term and medium-term 
animal assays have been published in the past 
decade, most of which do not comply with 
basic criteria (Kundi 2003), and there is no 
suitable model for brain tumors. Application 
of ethylnitrosourea during gestation results 
in an increased incidence of brain tumors but 
increases incidence of many other tumors as 
well. A further problem is the much smaller 
size of laboratory rodents, resulting in a 
completely different exposure pattern at tele-
communication frequencies. In contrast to 
humans using a mobile phone with a localized 
exposure at the side of the head the phone is 
held, animal exposure is a whole-body expo-
sure. Although devices have been constructed 
that result in a predominant head irradiation 
(Adey et al. 2000), pattern and distribution 
within the brain will still be completely differ-
ent from human exposures. It is not surpris-
ing then that up to now only a few animal 
experiments have found some indication of an 
increased cancer risk (e.g., Hruby et al. 2008; 
Repacholi et al. 1997; Shirai et al. 2007).
Interpretation of epidemiologic findings 
would be much easier if genotoxicity of mobile 
telecommunication signals could firmly be 
established. In vitro experiments have brought 
about diverse results that at present provide 
only equivocal evidence for genotoxic effects. 
Additionally, in the case of genotoxicity assays, 
procedures widely used for assessing envi-
ronmental and nutritional toxicants may not 
be ideally suited for the study of EMF. For 
example, if, as suggested by Lai and Singh 
(2004), exposure-induced effects imply activa-
tion of the Fenton reaction, cells rich in free 
iron would be responsive while others would 
not. Hence, overall evidence without consider-
ing mechanistic hypotheses is of limited value. 
Nevertheless, about one quarter of published 
genotoxicity studies found an effect of low-
level exposures (Vijayalaxmi and Obe 2004; 
Vijayalaxmi and Prihoda 2008). 
Overall, animal and in vitro experi-
ments do not reduce confidence in a causal 
relationship but do not provide unequivo-
cal support either. The main problem is the 
lack of a coherent research strategy that unifies 
strengths of different disciplines to unravel the 
intriguing problem of low-level EMF health 
effects from a biophysical perspective. 
Conclusions
Epidemiologic evidence compiled in the past 
10 years starts to indicate an increased risk, 
in particular for brain tumors (glioma, men-
ingioma, acoustic neuroma), from mobile 
phone use. Considering biases that may have 
been operating in most studies, the risk esti-
mates are rather too low, although recall bias 
could have increased risk estimates. The net 
result, when considering the different errors 
and their impact, is still rather an elevated 
risk. The magnitude of the brain tumor risk 
is moderate, but it has to be borne in mind 
that estimates are still from short durations 
of exposure. From the perspective of public 
health, an increase of brain tumor incidence 
of ≥ 50% poses substantial problems for 
neuro  surgical care, but the individual perspec-
tive is less dramatic: in industrial countries, 
the lifetime brain tumor risk is 4–8 per 1,000. 
If mobile phone use should increase these 
figures to 6–12 per 1,000, the individual risk 
is still low. Mobile phones and cancer
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At present, evidence for a causal relation-
ship between mobile phone use and brain 
tumors relies predominantly on epidemiology, 
in particular on the large studies of Hardell 
and colleagues, but there are no valid counter 
arguments and no strong evidence decreas-
ing confidence in a causal relationship. Weak 
evidence in favor of a causal relationship is 
provided by some animal and in vitro studies, 
but overall, genotoxicity assays, both in vivo 
and in vitro, are inconclusive to date. 
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